SCHEMBL30596999

SCHEMBL30596999

COc1cccc2nccnc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 5/20 0.55
KEAP1 Q14145 1/20 0.53
NFE2L2 Q16236 1/20 0.53
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
MAPT P10636 4/20 0.49
POLB P06746 3/20 0.49
RAB9A P51151 3/20 0.49
HTR1A P08908 2/20 0.49
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
NPC1 O15118 2/20 0.49
LMNA P02545 2/20 0.49
G6PD P11413 1/20 0.49
PKM P14618 1/20 0.49
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
USP2 O75604 1/20 0.48
PDE10A Q9Y233 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL622763 1.00 NQO2 (0.55) NQO2KEAP1NFE2L2MEN1KMT2A
SCHEMBL24005897 0.86 PDGFRB (0.52) NQO2KEAP1NFE2L2MEN1KMT2A
SCHEMBL3701516 0.78 MAPT (0.47) NQO2KEAP1NFE2L2MEN1KMT2A
SCHEMBL10780561 0.77 MEN1 (0.52) NQO2KEAP1NFE2L2MEN1KMT2A
SCHEMBL28783508 0.76 KDM4E (0.51) MEN1KMT2AMAPTPOLBRAB9A
SCHEMBL3731976 0.76 NQO2 (0.88) NQO2KEAP1NFE2L2MEN1KMT2A
SCHEMBL30363708 0.76 NQO2 (0.88) NQO2KEAP1NFE2L2MEN1KMT2A
SCHEMBL96953 0.75 SYK (0.57) KMT2AMAPTLMNAALDH1A1KDM4E
SCHEMBL29096082 0.75 SYK (0.57) KMT2AMAPTLMNAALDH1A1KDM4E
SCHEMBL170428 0.75 MEN1 (0.68) MEN1KMT2AMAPTPOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4504730-A1 DISCOVERY OF COVALENT EGFR INHIBITOR THROUGH CYSTEINE 775 Dana-Farber Cancer Institute, Inc. (US) 2025-02-12 EP disclosed
WO-2023196409-A1 DISCOVERY OF COVALENT EGFR INHIBITOR THROUGH CYSTEINE 775 DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-10-12 WO disclosed